Canadian Cannabis Corp Explains Move to Acquire 100% of Tree of Knowledge, Inc. and Signed LOI

U.S. Based CBD Manufacturer and Cannabis Industry Management Firm, Tree of Knowledge, Views Canada as a Prime Market for THC and CBD Product Quality Standardization

OAKVILLE, ON / ACCESSWIRE / December 20, 2016 / Canadian Cannabis Corporation ("CCAN" (OTC PINK: CCAN), or the "Company") is actively aligning resources to position the Company as an industry leader in the Canadian and global marijuana and hemp market place. CCAN is pleased to expand upon the details behind the announcement of a signed Letter of Intent ("LOI") to acquire 100% of Tree of Knowledge Inc., ("EVRCBD" https://evrcbd.com/) a vertically integrated producer and distributor of hemp-based cannabidiol ("CBD") products, located in Spokane, Washington.

By 2024, Health Canada projects the medical cannabis market in Canada will reach $1.3 billion. The Canadian cannabis marketplace's ability to legal import and export products containing tetrahydrocannabinol (THC) and cannabidiol (CBD) - two of the main components of the cannabis plant - is creating a wealth of new opportunities for companies located in Canada and investors. However, one of the key issues within the global cannabis industry is the ability to fully standardize this all-natural botanical into a commercially sold product. Canadian Cannabis Corp. is pleased to announce that it has identified a solution through the acquisition of Tree of Knowledge, Inc.

Tree of Knowledge, Inc.'s management team holds a proven track record of cannabis consulting and the development of commercial products in the hemp CBD industry; EVRCBD is a division of Tree of Knowledge, Inc. that is actively shipping CBD products worldwide. As industry leaders, Tree of Knowledge, Inc. has been instrumental in developing quality control processes that create standardization of cannabis-based products. Their efforts range from authorization by the Department of Health in Denver, Colorado for retail shelf stability of commercially sold CBD in dispensaries to shipping hemp CBD throughout the U.S. and as an international export.

"Our management team brings experience and knowledge of the cannabis industry from best-practices gained through use of THC and CBD products in the state of Washington," states Brian Main, CEO of Tree of Knowledge.

With a signed LOI to acquire 100% of Tree of Knowledge, Inc., CCAN has the opportunity to immediately create cannabis industry standards based on laboratory testing, certificates of analysis and quality control. CCAN's goal is delivery of the highest quality products containing THC and CBD on the market in Canada and around the world to ensure the safety and wellbeing of cannabis consumers.

Marcos Agramont, COO of Tree of Knowledge, states, "There is a critical need for quality and consistency with natural products including marijuana and hemp. What the LOI with Canadian Cannabis Corp. affords us is the opportunity to reach companies that are planning to legally import and export marijuana and hemp products from Canada. Our industry best-practices with quality assurance consistently produce the highest quality of products containing cannabinoids. We believe our efforts will create long-term customer satisfaction."

For more information on Canadian Cannabis Corporation, visit the Company's website at http://www.cdncannabis.com/

About Tree of Knowledge Inc.

EVRCBD, a division of Tree of Knowledge, Inc. is an emerging company in the high growth Cannabidiol (CBD) hemp oil industry, manufacturing the highest quality CBD products on the market today. All products are made with cannabinoids extracted from controlled strains of industrial hemp making them legal in all 50 states and 52 countries. The CBD contained in our products is extracted from organically grown hemp using a CO2 supercritical and proprietary extraction process whose output provides the purest product available today and without the use of toxic solvents. For more information, visit the Company's website at https://evrcbd.com/

About Canadian Cannabis Corp.

Canadian Cannabis Corp. is pursuing a business plan focused on entering strategic transactions in the distribution chain of medical marijuana. The Company believes its business model of engaging in strategic transactions to solidify the distribution chain by matching suppliers with a consistent demand source and providing suppliers with expert production consulting will bring a strategic advantage to the marketplace. For more information, visit the Company's website at http://www.cdncannabis.com/

Media Contact:

Denise Mahaffey
760.908.6565
denise@cannabisPRmedia.com

LEGAL DISCLOSURE

Canadian Cannabis Corp. and Tree of Knowledge, Inc. do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). Cannabidiol is a natural component of industrial hemp. EVRCBDs products are not intended to cure, mitigate or diagnose disease states.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "actively aligning," "pleased," "projects," "has the opportunity to," "believe," "will," or "affords us," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, competitive factors, the ability to successfully complete additional financings and other risks described in the Company's SEC reports and filings.

SOURCE: Canadian Cannabis Corp.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!